Free Trial

Pfizer (PFE) Stock Price, News & Analysis

Pfizer logo
$25.88 +0.32 (+1.23%)
As of 12:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pfizer Stock (NYSE:PFE)

Key Stats

Today's Range
$25.54
$26.05
50-Day Range
$22.01
$25.61
52-Week Range
$20.92
$31.54
Volume
17.09 million shs
Average Volume
45.83 million shs
Market Capitalization
$147.11 billion
P/E Ratio
18.75
Dividend Yield
6.65%
Price Target
$28.55
Consensus Rating
Hold

Company Overview

Pfizer Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

PFE MarketRank™: 

Pfizer scored higher than 98% of companies evaluated by MarketBeat, and ranked 12th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pfizer has received a consensus rating of Hold. The company's average rating score is 2.45, and is based on 5 buy ratings, 13 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Pfizer has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Pfizer's stock forecast and price target.
  • Earnings Growth

    Earnings for Pfizer are expected to grow by 2.71% in the coming year, from $2.95 to $3.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pfizer is 18.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.72.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pfizer is 18.85, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.44.

  • Price to Earnings Growth Ratio

    Pfizer has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Pfizer has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pfizer's valuation and earnings.
  • Percentage of Shares Shorted

    1.88% of the float of Pfizer has been sold short.
  • Short Interest Ratio / Days to Cover

    Pfizer has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pfizer has recently increased by 1.66%, indicating that investor sentiment is decreasing.
  • Dividend Leadership

    Pfizer is a leading dividend payer. It pays a dividend yield of 6.71%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Pfizer has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Pfizer is 124.64%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Pfizer will have a dividend payout ratio of 56.77% next year. This indicates that Pfizer will be able to sustain or increase its dividend.

  • Read more about Pfizer's dividend.
  • Percentage of Shares Shorted

    1.88% of the float of Pfizer has been sold short.
  • Short Interest Ratio / Days to Cover

    Pfizer has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pfizer has recently increased by 1.66%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pfizer has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 100 news articles for Pfizer this week, compared to 65 articles on an average week.
  • Search Interest

    192 people have searched for PFE on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.
  • MarketBeat Follows

    Only 52 people have added Pfizer to their MarketBeat watchlist in the last 30 days. This is a decrease of -27% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pfizer insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.06% of the stock of Pfizer is held by insiders.

  • Percentage Held by Institutions

    68.36% of the stock of Pfizer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pfizer's insider trading history.
Receive PFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat's FREE daily newsletter.

PFE Stock News Headlines

European Commission president Ursula von der Leyen delivers her speech during a statement on the pr…
EU official Ursula von der Leyen comfortably survives a confidence vote
European Commission President Ursula von der Leyen has comfortably survived a vote of no confidence...
High Dividend Yield odometer - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
Top 5 Undervalued Dividend Stocks With Strong Payout Potential (PFE)
Seemingly undervalued dividend stocks, such as BAC, F, MO, VZ, and PFE, offer a rare combination of strong yields and attractive valuations.
How a Kansas farm boy gained 1,285% in two days
A former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a meme stock. It was a pattern called “Crossfire” — a 3-step setup you can execute in a normal brokerage app. Master trader Jeff Clark is now revealing how it works in a free 30-minute video, available for a limited time.
- Related Stocks: NYSE:PFE,
See More Headlines

PFE Stock Analysis - Frequently Asked Questions

Pfizer's stock was trading at $26.53 at the start of the year. Since then, PFE shares have decreased by 1.9% and is now trading at $26.0140.

Pfizer Inc. (NYSE:PFE) announced its quarterly earnings results on Tuesday, April, 29th. The biopharmaceutical company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.25. Pfizer's quarterly revenue was down 7.8% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Pfizer: ReViral, Arena, Trillium Therapeutics, Amplyx Pharmaceuticals, Array BioPharma, Therachon, Medivation, and others.

Top institutional shareholders of Pfizer include Swedbank AB (0.08%), OLD Republic International Corp (0.03%), Sarasin & Partners LLP (0.03%) and Czech National Bank (0.02%). Insiders that own company stock include Pfizer Inc, Ronald E Blaylock and Scott Gottlieb.
View institutional ownership trends
.

Shares of PFE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pfizer investors own include Scilex (SCLX), Salesforce (CRM), Chevron (CVX), AbbVie (ABBV), Johnson & Johnson (JNJ), Meta Platforms (META) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
4/29/2025
Record date for 6/13 Dividend
5/09/2025
Ex-Dividend for 6/13 Dividend
5/09/2025
Dividend Payable
6/13/2025
Today
7/10/2025
Record date for 9/2 Dividend
7/25/2025
Ex-Dividend for 9/2 Dividend
7/25/2025
Next Earnings (Estimated)
8/05/2025
Dividend Payable
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PFE
CIK
78003
Employees
81,000
Year Founded
1849

Price Target and Rating

High Price Target
$34.00
Low Price Target
$23.00
Potential Upside/Downside
+11.7%
Consensus Rating
Hold
Rating Score (0-4)
2.45
Research Coverage
22 Analysts

Profitability

Trailing P/E Ratio
18.52
Forward P/E Ratio
8.66
P/E Growth
0.93
Net Income
$8.03 billion
Pretax Margin
11.83%

Debt

Sales & Book Value

Annual Sales
$63.63 billion
Cash Flow
$4.35 per share
Price / Cash Flow
5.87
Book Value
$15.62 per share
Price / Book
1.64

Miscellaneous

Outstanding Shares
5,685,370,000
Free Float
5,681,955,000
Market Cap
$145.32 billion
Optionable
Optionable
Beta
0.58

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:PFE) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners